Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sunesis begins phase III vosaroxin trial in acute myeloid leukemia

Dec. 24, 2010

Promising phase I data on CAL-101 in hematological malignancies disclosed

Dec. 24, 2010

CHMP recommends approval of Teysuno for treatment of advanced gastric cancer

Dec. 23, 2010

Oncothyreon begins phase I/II trial of PX-866/cetuximab combination

Dec. 23, 2010

Applications for abiraterone acetate submitted to FDA and EMA

Dec. 23, 2010

New class of toluidine sulfonamides set to enter clinical testing for the treatment of MM

Dec. 23, 2010

Phase III trial of INC-424 in myelofibrosis meets primary endpoint

Dec. 22, 2010

Cyclacel reports topline data from phase IIb APPRAISE trial of seliciclib

Dec. 22, 2010

Abbott divulges new inhibitors of IGF-I receptor

Dec. 22, 2010

LY-2784544 inhibits V617F-mutant JAK-2 signaling and advances through clinical development

Dec. 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...